Abstract |
|
Authors | A G Turpie, J I Weitz, J Hirsh |
Journal | Thrombosis and haemostasis
(Thromb Haemost)
Vol. 74
Issue 1
Pg. 565-71
(Jul 1995)
ISSN: 0340-6245 [Print] Germany |
PMID | 8578525
(Publication Type: Comparative Study, Journal Article, Review)
|
Chemical References |
- Antithrombins
- Factor Xa Inhibitors
- Fibrinolytic Agents
- Hirudins
- Lipoproteins
- Peptide Fragments
- Platelet Aggregation Inhibitors
- Protein C
- Recombinant Proteins
- lipoprotein-associated coagulation inhibitor
- Aspirin
- bivalirudin
|
Topics |
- Angina, Unstable
(drug therapy)
- Angioplasty, Balloon, Coronary
- Antithrombins
(therapeutic use)
- Aspirin
(therapeutic use)
- Clinical Trials as Topic
- Clinical Trials, Phase II as Topic
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Design
- Drug Therapy, Combination
- Enzyme Activation
(drug effects)
- Factor Xa Inhibitors
- Fibrinolytic Agents
(adverse effects, classification, therapeutic use)
- Hemorrhage
(chemically induced, epidemiology)
- Hirudin Therapy
- Hirudins
(adverse effects, analogs & derivatives)
- Humans
- Lipoproteins
(therapeutic use)
- Myocardial Infarction
(drug therapy)
- Myocardial Ischemia
(drug therapy)
- Peptide Fragments
(adverse effects, therapeutic use)
- Platelet Aggregation Inhibitors
(therapeutic use)
- Postoperative Complications
(prevention & control)
- Protein C
(metabolism)
- Randomized Controlled Trials as Topic
- Recombinant Proteins
(adverse effects, therapeutic use)
- Thrombolytic Therapy
(adverse effects, trends)
- Thrombophlebitis
(drug therapy)
- Treatment Outcome
|